Thursday, August 8, 2019
Wednesday, August 7, 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (CSE: $CBDT.C) (TSX: $TGOD.TO)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $KHRN.V) (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (CSE: $CBDT.C) (TSX: $TGOD.TO)
Delta, Kelowna, BC –August 7, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/08071KHRN-DIXI-DXBRF-CBDT-TGOD.asp
In today’s podcast we look at a few early announcements.
But first, Strainprint™ Technologies Ltd. has launched the next stage of the much-anticipated clinical trial with Israeli based research group Gynica to develop a product formulation to treat endometriosis and its symptoms. This phase will include asking endometriosis sufferers in Canada and Israel to complete an anonymous, comprehensive custom questionnaire about how they use cannabis to treat their symptoms.
Strainprint, the leader in cannabis data and analytics partnered with Israeli researchers at Gynica, a leader in cannabis-based solutions for women's health, in late 2018 to conduct the world's first international clinical study on the use of cannabis to treat endometriosis. The study will leverage Strainprint's database of patient reported outcomes among those who use cannabis to treat endometriosis, which, along with the results of this questionnaire will inform the formulation of a cannabis-based product which will be clinically validated and then available for purchase.
Endometriosis affects approximately 1 in 10 women and it is a condition with limited understanding and treatment options.
“180 million people worldwide experience severe pain daily as a result of tissue similar to the uterine lining migrating to other organs inside the body, causing debilitating pain, infertility, fatigue, gastrointestinal and/or bladder symptoms," says Gynica's Professor Moshe Hod, President of the European Association of Perinatal Medicine and Professor of Obstetrics and Gynecology at Tel Aviv University medical school. "Our objective is to recruit suffering candidates to explore cannabis as a viable therapy in the hopes of developing improved diagnostics and treatments to those who are undertreated by current solutions."
"We believe many women will be eager to take part in this ground-breaking research," says Michelle Arbus, Strainprint's VP of Research. "Our online Strainprint Community already provides a safe space to discuss endometriosis and cannabis treatment with fellow sufferers, and through this questionnaire, participants will have the opportunity to contribute to research and play a more active role in their healthcare with alternative methods not yet explored. Some of these endometriosis sufferers have dealt with excruciating pain for many years and do not tolerate or respond to the current treatment options available. They will now have a chance to be pioneers in a study that could make medical history by helping others not only manage their symptoms, but also greatly improve their quality of life."
Survey participants must be 18 years or older and currently suffer from endometriosis. Once they register to the Strainprint Community, they can request access to an exclusive group, only open to questionnaire participants, giving them access to the questionnaire, forums, specialized endometriosis education materials and more.
Here is how interested candidates can participate:
- Go to https://strainprint.ca/community/groups/endometriosis/
- Click Join the Community or already a member? login here
- You'll be returned to the Endometriosis Group where you'll click request membership.
- Once your group membership has been approved, and you enter the group, click on the survey link.
Once this phase of the study is complete, respondents from both Canada and Israel will be asked if they would like to participate in a clinical trial of a cannabis-based therapy.
Khiron Life Sciences Corp. (TSXV: KHRN)(OTCQB: KHRNF) announced today that it has signed a distribution agreement for its Kuida cosmeceutical brand with Grupo Éxito, Colombia´s market leading retail group and one of the largest retailers in South America.
Grupo Éxito is a Colombian retailer with a successful 110-year presence in the Latin American market and is the only retail company in the region included in the Dow Jones Sustainability index, under the "Emerging Markets" category. Controlled by Casino Guichard-Perrachon and with revenues of U.S.$17 billion in 2018, Grupo Éxito operates 1,533 stores across Colombia, Uruguay, Brazil and Argentina, including 252 Éxito stores and 9 Éxito WOW stores. Under the Company's agreement with Grupo Éxito, Kuida will initially be sold in 5 Éxito WOW stores and 16 traditional format stores.
Introduced by Grupo Éxito in 2018, Éxito WOW represents a new store format aimed at delivering innovative, digitally-integrated customer experiences throughout the Cali, Bogotá, Medellín, and Barranquilla regions of Colombia among others. On introduction to Éxito WOW stores, Kuida will form a cornerstone product line for the retailer's cannabis products category. To support Kuida sales and brand awareness, each Éxito WOW location will host dedicated experience centres, with skin expert consultants on-hand to educate consumers on the brand's proprietary CBDERM technology, as well as its current portfolio of seven skin and personal care products.
Khiron Life Sciences Corp. and Dixie Brands Inc. (CSE: DIXI.U) (OTCQX: DXBRF) also announced that their previously disclosed 50/50 Joint Venture has received conditional approval from the TSX Venture Exchange. With this approval in place, Khiron and Dixie will begin the process of commercialization of the Kuida cosmeceutical product line in the U.S. marketplace, as well as the introduction of Dixie's CBD-infused products into Latin America.
Through the JV, Dixie will be responsible for the distribution of Khiron's portfolio of Kuida cosmeceutical products in the U.S. Kuida products will be broadly distributed through Dixie's established distribution network to U.S. consumers, and are expected to have particular appeal to the growing U.S. Hispanic population, estimated at nearly 60 million.
Further, the conditional TSXV approval allows for the manufacture and commercialization of Dixie's products in Latin America, leveraging Khiron's legislative, sales and marketing abilities and Dixie's extensive and market-proven product line. It is anticipated that Dixie CBD-based products will be commercialized in Latin America beginning in 2020. The JV also creates a framework for the development of new products and brands tailored to Latin America, allowing Dixie and Khiron to take full advantage of opportunities resulting from advancements in cannabis legalization in the region. The conditional TSXV approval covers operations in Colombia, Chile and Uruguay; additional applications will be made to the TSXV as more Latin American countries legalize the use of cannabis.
Alvaro Torres, Khiron CEO and Director, comments: "With a strong JV leadership, sales and marketing team in place, this regulatory approval positions us to accelerate activities in both our core Latin American markets and in the U.S. Bringing the full Kuida product line to U.S. consumers is an important development as we build capacity and market access to expand Kuida brand distribution into new jurisdictions globally."
Dixie Brands Inc. and AriZona, maker of the #1 selling iced tea in America, also announced signing a binding letter of intent on Friday, August 2nd, 2019, to partner for the production, distribution and sale of cannabis-infused products containing THC.
Under the terms of this deal between Dixie Brands Inc., and the AriZona™ brand, through its affiliated entity, Herbal Enterprises, LLC, will direct brand and product conceptual design; while Dixie Brands will develop, formulate, manufacture and distribute the new portfolio of AriZona branded THC infused consumer packaged goods.
"AriZona has always led the way in product innovation," said Don Vultaggio, Chairman, AriZona Beverages. "The cannabis market is an important emerging category, and we've maintained our independence as a private business to be positioned to lead and seize generation-defining opportunities exactly like this one. The Cannabis category is an ideal space to bring the flavor and fun of AriZona into new and exciting products, and we selected Dixie Brands as our partner to bring these products to market after touring their best in class manufacturing facilities, and spending considerable time building a strong relationship with their management. Both companies share a heritage of quality, excellence in manufacturing, and doing things the right way, and we look forward to all this partnership has in store."
"AriZona is a power brand," said Chuck Smith, CEO Dixie Brands, "and the most iconic and recognized CPG brand to extend into the cannabis market, providing the evolving cannabis consumer with a fun and flavorful experience alongside an iconic brand they know and love. For nearly a decade Dixie Brands has crafted award-winning cannabis-infused products creating some of the most recognized and trusted brands in the industry, and we are thrilled to have found a partner that shares our values. This partnership marks a watershed moment for the popularization and expansion of the cannabis sector overall, and is another large step forward for Dixie Brands' strategy to build a house of famous cannabis CPG brands."
EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) announced that it has entered into a strategic partnership with Endocanna Health Inc., a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis (CSE: CANN).
Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits for and license its proprietary DNA technology to Empower. Empower will immediately make the Endocanna kits available to its corporate owned medical clinics that include 165,000 patients in Oregon, Arizona, Washington State and Nevada. The Company plans to include the DNA Test Kits as a standard offering in the Sun Valley Health franchise program, and has commenced it's roll-out in the United States.
"We continue to focus our initiatives on patient care and wellbeing, ensuring we have the ability to provide best-in-class care and advice using the most advanced technology available." said Steven McAuley, Empowers Chairman & CEO. "The Endocanna DNA Test Kit can give our physicians the potential to have even greater insight into each individual patient's propensity for success, on how CBD based therapies may interact with their individual regulatory system."
The Kits are designed to provide consumers with personalized data about how cannabidiol (CBD) and other cannabinoids may interact with their body, plus the technology may allow the company to provide patients with science-backed cannabis product suggestions based on their specific DNA.
"Using Endocanna Health's proprietary DNA report, we can personalize and provide a cannabinoid wellness protocol tailored to an individual's needs." said Len May, CEO & Co-Founder of Endocanna Health. "Empower and their Sun Valley Health clinic network, provides an immediate opportunity for us to work with physicians and patients to develop advanced science surrounding the endocannabinioid system and CBD based therapies."
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) announced that it has submitted an application to list its common shares on the NASDAQ.
The listing of TGOD's shares on the NASDAQ will be subject to a number of regulatory requirements, including registration of the common shares under the U.S. Securities Exchange Act of 1934 and a determination by the NASDAQ that TGOD has satisfied all applicable listing requirements. Subject to approval for listing, the common shares will continue to trade on the TSX Exchange (TSX) under 'TGOD', which is also the reserved symbol for the NASDAQ application.
"This is an important step in the growth of TGOD, one that will broaden our investor base and increase access for international investors as we build the leading global organic cannabis brand,'' commented Brian Athaide, CEO of TGOD. "Our team remains focused on executing our business plan and creating value for our shareholders."
Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B) and Fire & Flower Holdings Corp. (TSX: FAF) today confirmed the closing of their transaction previously announced on July 24, 2019. In addition, the common shares in the capital of Fire & Flower commenced trading on the Toronto Stock Exchange as of August 7, 2019.
The Transaction includes the issuance today by Fire & Flower of an 8.0% unsecured convertible debenture to an indirect wholly-owned subsidiary of Couche-Tard in the aggregate principal amount of approximately $26.0M, which principal amount of debenture is convertible by the Investor into 24,289,706 Common Shares at a price of $1.07 per Common Share, representing a 9.9% ownership interest in Fire & Flower on a pro forma fully-diluted basis. The Investor has also been issued Common Share purchase warrants that, if exercised in full in accordance with the terms thereof, will subsequently increase the Investor's ownership interest to 50.1% of Fire & Flower on a pro forma fully-diluted basis.
In connection with the closing of the Transaction, Fire & Flower announced the appointment of Jeremy Bergeron as Couche-Tard's initial nominee to Fire & Flower's board of directors.
"Through this strategic investment, we reinforce our intention to become a key player in North America's cannabis industry," said Brian Hannasch, President and CEO of Couche-Tard. "We are excited to see what we can achieve together with Fire & Flower, as we further expand in Canada and look to leverage our presence in the United States and beyond."
"Combining Couche-Tard's expertise in scaling retail stores with Fire & Flower's retail experience and proprietary HifyreTM digital platform positions our company extremely well to capitalize on new cannabis markets as they emerge," added Trevor Fencott, Fire & Flower's Chief Executive Officer.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Skin and Hair Treatment Trending; Plant Based and #Organic Products Demand (OTCQB: $RVIV) (NYSE: $EPC) (NYSE: $NUS) (CSE: $GGB.C)
Skin and Hair Treatment Trending; Plant Based and #Organic Products Demand (OTCQB: $RVIV) (NYSE: $EPC) (NYSE: $NUS) (CSE: $GGB.C)
Point Roberts WA, Delta BC – August 7, 2019 - Investorideas.com, a leading investor news resource covering wellness and cannabis stocks releases a sector snapshot reporting on the continued growth being seen in the global skin and hair care market as consumer awareness, demand for organic products, global temperatures and UV exposure all continue to rise.
The hair care market is forecast to reach USD 116.33 billion by 2024, registering a CAGR of 3.35% during the forecast period (2019 - 2024).
A recent report showed that “the growing demand for organic/natural products for personal grooming has become one of the primary concerns for individuals. Among organic hair care products, owing to its wide usage, conditioners and shampoos held a majority share in the global organic haircare market in 2018. Furthermore, anti-dandruff organic hair oils are expected to register robust growth over the forecast period.”
Reviv3 Procare Company (OTCQB: RVIV), a company engaged in the manufacturing, marketing, sale and distribution of premium quality hair and skin care products under various trademarks and brands announced that it plans to launch multiple product sets of its plant-based products at Costco locations in the United Kingdom.
Read this in full at https://www.investorideas.com/news/2019/lohas/08071SkinHairTreatment-RVIV-EPC-NUS-GGB.asp
Donald Starace, President of REVIV3, said “As part of our international market expansion strategy, our customized product set offerings for Costco, UK will provide exposure to a market that until now has not been able to experience the amazing benefits we provide in hair and scalp health. It is our ultimate goal to be the primary destination for anyone looking for drug-free alternatives to improve follicle structural properties, nourish and rejuvenate hair.” Mr. Starace continued, “We believe the quality and effectiveness of our hair products is our most powerful marketing tool and the primary driver of our customer referrals and retention.”
The product lines for Costco, UK are planned for launch in September 2019 and will include a deep cleanser shampoo, moisturizing conditioner, hair follicle treatment, hair thickening spray and thermal protectant spray. The products are formulated with premium plant-based peptides and active botanicals formulated for safe and effective daily use.
Reviv3 is currently expanding its sales channels domestically and across the globe with customized product offerings in new markets. The recent expansions include agreements with Asian distribution partners for sale of Reviv3 products in TMALL.com and JD.COM as reported in the company’s press release on June 5, 2019. In conjunction, the company has continued to build on its operational efficiencies which according to Reviv3’s annual results on July 19, resulted in a 16.8% decrease in operating expenses for FY2019, compared to the same period last year.
We are also seeing strings of acquisitions and mergers to help companies meet the increased need for larger distribution and production capabilities in this growing market.
Edgewell Personal Care Company (NYSE: EPC) and Harry's, Inc. announced in May that they entered into a definitive agreement under which Edgewell would combine with Harry's in a cash and stock transaction that values Harry's at $1.37 billion. The combination of Edgewell and Harry's brings together complementary capabilities to create a next-generation consumer products platform with an expansive runway for accelerated topline growth and enhanced value creation.
Together, Edgewell and Harry's will create a platform that enables building and scaling the next generation of impactful consumer brands. Harry's has been a disruptive force across the men's and women's shaving market and adjacent grooming and personal care categories. Its demonstrated expertise in brand building and direct-to-consumer marketing are a complementary fit with Edgewell's strong intellectual property, best-in-class product technology, global scale and stable of strong consumer brands. The combined company will have a leading portfolio of global brands in men's and women's shaving, personal and sun and skin care.
Andy Katz-Mayfield and Jeff Raider, Harry's Co-Founders and Co-CEOs, have agreed to join the Executive Team of Edgewell at closing, to serve as Co-Presidents of US operations.
"The combination of Edgewell and Harry's is a pivotal step forward in further transforming our organization and strengthening our competitive position and ability to drive sustained growth and value creation," said Rod Little, Edgewell's President and Chief Executive Officer. "Building on Edgewell's and Harry's complementary strengths, our combined company will have leading brands and omni-channel capabilities that are essential to meet the needs of the modern consumer and win in today's market environment. We welcome Harry's entrepreneurial employees and look forward to working closely with Andy and Jeff, whose ingenuity and demonstrated success will enable us to take our U.S. business to the next level. We are excited about our future and the opportunities we have to deliver superior long-term shareholder returns as a next-generation CPG platform."
Andy Katz-Mayfield and Jeff Raider, Co-Founders and Co-CEOs of Harry's, said "When we launched Harry's six years ago our vision was to create a grooming brand that better met our needs as consumers, and over time, a CPG platform that creates brands people love across more categories. Together with Edgewell, we see a significant opportunity to continue delivering on that vision, leveraging Edgewell's advanced technology and global footprint alongside our customer-first approach, brand building expertise and omni-channel capabilities. We're incredibly proud of the brands we've created and the team we've built, and have tremendous respect for Edgewell and its established brand portfolio. We look forward to what we can accomplish together."
ResearchAndMarkets.com recently released the "Skin Care Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" which discussed the trends in the global skincare market, noting that the market was worth US$ 128.9 Billion in 2018 and projected to reach a value of US$ 165.9 Billion by 2024, registering a CAGR of around 4% during 2019-2024.
The report continued, “Skin is one of the organs that receive the most damage owing to the exposure to external factors such as ultraviolet (UV) rays and pollution. Consequently, there has been an increase in the inclination among the masses towards engaging in a regular skin care regime, thus making it an integral part of personal well-being. This has led to the introduction of diversified products containing various chemical and herbal elements, aiming at the overall enhancement and maintenance of healthy skin. Urban regions, in particular, have been a witness to increasing consumers' inclination toward various skin care products owing to rising disposable income, aggressive promotional activities, and launch of innovative products by manufacturers. Rising awareness about both skin ailments and available treatments is propelling consumers to start using skin care products quite early, thus aiding the market growth. The market is further driven by an increasing number of women preferring anti-aging products which form a crucial segment of the skin care products market.”
As these factors influence the market we see more companies looking to expand their product portfolios as well as enter into new international marketplaces which are joining this skincare and wellness trend.
Nu Skin Enterprises, Inc. (NYSE: NUS) recently announced their estimated second-quarter results and updated its outlook for full-year 2019. The company anticipates reporting second-quarter revenue between $622 and $623 million and earnings per share of $0.82 to $0.84. The company's revised revenue outlook for 2019 is $2.48 to $2.52 billion with a negative foreign currency impact of approximately 4 percent, and earnings per share of $3.20 to $3.35.
"We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government's 100-day campaign to review and inspect the health products and direct selling industries," said Ritch Wood, Chief Executive Officer. "Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment. While we anticipated we could begin holding meetings in the second quarter, meeting approvals for the industry have been significantly more restrictive than expected and remain limited. Additionally, the U.S. dollar has continued to strengthen, and we have adjusted our 2019 guidance to include a larger-than-anticipated foreign currency impact. We will provide more detail regarding results for the second quarter in our earnings release scheduled for Aug. 6."
Several institutional investors increased or changed their position leading up to the results such as Handelsbanken Fonder AB who increased its position in Nu Skin by 25.0%, Delek Group Ltd. who purchased a new position in shares of Nu Skin Enterprises, Amalgamated Bank who raised its holdings in shares of Nu Skin Enterprises by 14.8% and Trexquant Investment LP who raised its holdings in shares by 7.0%.
Several research firms have also weighed in on NUS such as Zacks Investment Research who raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Friday, May 3rd and ValuEngine who raised shares from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 1st.
CBD is also playing an important role in these markets with companies such as Green Growth Brands Inc. (CSE: GGB) (OTC: GGBXF) who announced it has received a purchase order from American Eagle Outfitters, Inc. through which it will sell hemp-derived cannabidiol (CBD) infused personal care products in nearly 500 American Eagle (AE) stores and American Eagle Outfitters, Inc.’s online website.
The purchase order represents GGB's third major wholesale agreement since the passage of the Agriculture Act of 2018 in December 2018 (the 2018 Farm Bill).
The products, which were exclusively developed for American Eagle include a wide assortment of CBD-infused personal care items such as lotions, muscle balms, and aromatherapy. Sales of the product are expected to begin in October 2019.
"We are very pleased to be partnering with American Eagle, a leader in the specialty retail space," said Green Growth Brands CEO, Peter Horvath. "GGB provided the expertise necessary to develop the product formulations and packaging to create a really special line of products."
All Green Growth Brands CBD products are sourced from US-based, licensed hemp processors and comply with the 2018 Farm Bill. GGB sells and distributes topical CBD products only in jurisdictions that permit such sale.
Quality organic products are becoming a majority trend not just in the US and EU but also increasingly in every corner of the world. This increased awareness of product quality in the global consumer is forcing companies to adapt, which in turn is benefiting the consumer and their overall health and wellness.
For investors following stocks and Health, Wellness & Sustainability stocks, InvestorIdeas.com has created stock directories to research each sector. Learn more about our membership and directories: https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: This industry article featuring RVIV is a paid for service on Investorideas (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get more Health, Wellness and Sustainability Stock Investor Ideas- news, articles, podcasts and stock directories
Tuesday, August 6, 2019
Investorideas.com - Cannabis Stock News: Bhang (CSE: BHNG) Brings Hemp-derived CBD Product Portfolio to Spain, France, Italy, Belgium, Luxembourg & the U.K.
Investorideas.com - Cannabis Stock News: Bhang (CSE: BHNG) Brings Hemp-derived CBD Product Portfolio to Spain, France, Italy, Belgium, Luxembourg & the U.K.
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Celebrates Opening More Than 100 CBD Shops In Seven Months
Investorideas.com - Cannabis Stock News: Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Celebrates Opening More Than 100 CBD Shops In Seven Months
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)